Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings
Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

951
1
ZEVRA THERAPEUTICS, INC. Zevra Therapeutics Reports Net Loss of $33.2M, Increased Expenses, and Debt in Latest Quarter

Via official filing (AI summary) | 9 days ago | 0 comments

952
1
Sarcos Technology & Robotics Corp Palladyne AI Corp. Reports Mixed Financial Results, Focuses on AI/ML Software Platform Development

Via official filing (AI summary) | 9 days ago | 0 comments

953
1
American Oncology Network, Inc. American Oncology Network Reports 39.8% Revenue Growth, Narrowed Net Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

954
1
Structure Therapeutics Inc. Structure Therapeutics Reports $33.98M Net Loss, Increases Research and Development Expenses in Latest Quarter

Via official filing (AI summary) | 9 days ago | 0 comments

955
1
MEDICINOVA INC MediciNova Reports Significant Revenue Decline and Net Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

956
1
Dermata Therapeutics, Inc. Dermata Therapeutics Reports Net Loss of $3.2M in Q3 2024, Increases Research and Development Expenses

Via official filing (AI summary) | 9 days ago | 0 comments

957
1
Energous Corp Energous Corporation Reports Q3 2024 Financial Results, Net Loss of $3.4 Million

Via official filing (AI summary) | 9 days ago | 0 comments

958
1
RenovoRx, Inc. RenovoRx Reports Improved Financials, Raises $17.2M in Private Placements, and Advances Clinical Trials

Via official filing (AI summary) | 9 days ago | 0 comments

959
1
Microbot Medical Inc. Microbot Medical Inc. Reports Continued Operating Losses and Decrease in Total Assets and Shareholders' Equity

Via official filing (AI summary) | 9 days ago | 0 comments

960
1
Armata Pharmaceuticals, Inc. Armata Pharmaceuticals Reports 142.7% Increase in Grant Revenue, Net Loss Decrease in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

961
1
NSTS Bancorp, Inc. NSTS Bancorp Reports Improved Q3 Net Loss, Increased Lending and Assets

Via official filing (AI summary) | 9 days ago | 0 comments

962
1
Enliven Therapeutics, Inc. Enliven Therapeutics Reports Increased Assets, Continued Operating Losses in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

963
1
NATURAL ALTERNATIVES INTERNATIONAL INC Natural Alternatives International Reports Decline in Financial Performance, Net Loss Increases 185%

Via official filing (AI summary) | 9 days ago | 0 comments

964
1
EVOLUTION PETROLEUM CORP Evolution Petroleum Reports 6.3% Revenue Growth, Net Income Increase in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

965
1
KULR Technology Group, Inc. KULR Technology Group Reports 5% Q3 Revenue Growth, Improved Profitability, and Strategic Developments

Via official filing (AI summary) | 9 days ago | 0 comments

966
1
CF Acquisition Corp. VII CF Acquisition Corp. VII Reports Financial Results for Q3 2024, Net Loss and Decreased Assets

Via official filing (AI summary) | 9 days ago | 0 comments

967
1
MIDDLEFIELD BANC CORP Middlefield Banc Corp. Reports Mixed Q3 and Nine-Month Results, Net Income Down 39% and 22.8%

Via official filing (AI summary) | 9 days ago | 0 comments

968
1
Cantor Equity Partners, Inc. Cantor Equity Partners Reports Significant Financial Progress, Net Income Turnaround in Latest Quarter

Via official filing (AI summary) | 9 days ago | 0 comments

969
1
GRAIL, Inc. GRAIL Reports 38% Revenue Growth, Net Loss of $125.7M in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

970
1
LANDMARK BANCORP INC Landmark Bancorp Reports 36.6% Increase in Net Earnings for Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

971
1
Tarsus Pharmaceuticals, Inc. Tarsus Pharmaceuticals Reports Significant Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

972
1
BayFirst Financial Corp. BayFirst Financial Corp. Reports Mixed Financial Results for Q3 2024, Focuses on Core Business and Capital Strength

Via official filing (AI summary) | 9 days ago | 0 comments

973
1
NEXTNAV INC. NextNav Inc. Reports 56.5% Revenue Growth, Improved Operating Loss in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

974
1
Maplebear Inc. Instacart Reports 12% Revenue Growth, Returns to Profitability in Q3 2024

Via official filing (AI summary) | 9 days ago | 0 comments

975
1
Elicio Therapeutics, Inc. Elicio Therapeutics Reports Net Loss of $18.8M, Increases Cash Reserves to $26M in Latest Quarter

Via official filing (AI summary) | 9 days ago | 0 comments